The Microbiology of Caries Resistance

November 7, 2016 updated by: University of Florida

The Microbiology of Caries Resistance. Subtitle: Functional Amyloid Formation in Streptococcus Mutans

The purpose of this research study is to investigate the bacterial composition of plaque and saliva located in the mouth and associate that with risk factors that cause cavities.

Study Overview

Detailed Description

Pre-Screening - If the subject chooses to be pre-screened for this study they will be asked to fill out a study registration form and an oral habits/medical history form. They will be asked to sign an Informed Consent. The subject will then have their teeth and gums examined. At this visit, the investigator will assess whether or not the subject is a good candidate for the study. During the phone interview each subject was asked not to brush or floss their teeth and not to eat or drink anything other than water for 8 hours prior to the pre-screening visit (Visit 0). If the subject was compliant with these requests, oral samples will be collected at this pre-screening visit and will now be considered Visit 1 (Baseline). If not, they will be asked to return to the clinic for another visit and asked not to brush or floss their teeth and not to eat or drink anything other than water 8 hours prior to that appointment. This visit will then be consider Visit 1 (Baseline).

Visit 1 (Baseline) - The subject will have their medical and dental history reviewed. They will have their teeth and gums examined. Saliva and plaque will be collected. Each subject will be given a toothbrush and toothpaste and instructed to not use any other dental products. This will be considered the "washout" period.

Visit 2 - The subject will be asked to return the unused toothpaste. Their medical and dental history will be reviewed and they will have their teeth examined. Saliva and plaque will be collected at this visit. The subjects will then be randomly assigned (by chance, like the flip of a coin) to the group that will use a marketed fluoride-containing toothpaste or to the group that will use a marketed arginine containing toothpaste. The subject will also be instructed not to brush or floss their teeth or eat or drink anything other than water for 8 hours prior to your next appointment.

Visits 3, 4, and 5 - Subjects will not be allowed to brush or floss their teeth or eat or drink anything other than water 8 hours prior to these visits. Saliva and plaque will be collected. On the 5th visit subjects will be asked to return the unused toothpaste tube. At this time participation in this research study will end and they will be instructed to return to their regular oral hygiene regiments.

Study Type

Interventional

Enrollment (Actual)

79

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Gainesville, Florida, United States, 32610
        • University of Florida College of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Twenty natural teeth excluding third molars
  • No contraindications to dental treatment
  • Caries Free
  • Caries Active (at least two active sites)

Exclusion Criteria:

  • Less that twenty teeth
  • Any systemic disease that can cause xerostomia
  • Taking medications that cause xerostomia
  • Antibiotics last three months
  • Advanced Periodontal Disease
  • Removable or fixed dental appliances
  • Bleeding disorders or taking anticoagulant medications
  • Immune compromised individuals
  • Participating in another research study
  • Used flavored products such as mint flavored candies and chewing gum one week prior to or during the study
  • Uses tobacco products
  • Unwilling or unable to provide Informed Consent and follow collection instructions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Caries Free
Gums will be examined. On some visits Saliva and plaque will be collected. Toothpaste assigned will include DenClude 1.5% Arginine.
Gums will be examined. On some visits Saliva and plaque will be collected. Toothpaste assigned will include DenClude 1.5% Arginine.
Placebo Comparator: Caries Free - Placebo
Gums will be examined. On some visits Saliva and plaque will be collected. Marketed Toothpaste will be assigned.
Gums will be examined. On some visits Saliva and plaque will be collected. Marketed Toothpaste will be assigned.
Active Comparator: Caries Active
Gums will be examined. On some visits Saliva and plaque will be collected. Toothpaste assigned will include DenClude 1.5% Arginine.
Gums will be examined. On some visits Saliva and plaque will be collected. Toothpaste assigned will include DenClude 1.5% Arginine.
Placebo Comparator: Caries Active - Placebo
Gums will be examined. On some visits Saliva and plaque will be collected. Marketed Toothpaste will be assigned.
Gums will be examined. On some visits Saliva and plaque will be collected. Marketed Toothpaste will be assigned.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Levels of the arginine deiminase system (ADS) in oral samples of healthy and caries-active subjects changes from baseline to month 2
Time Frame: Changes from baseline to month 2 (Screening)
Saliva and dental plaque will be collected during the study visit. The amount of ammonia produced via the ADS by oral bacteria present in the collected oral samples will be measured using a standardized protocol.
Changes from baseline to month 2 (Screening)
Levels of the arginine deiminase system (ADS) in oral samples of healthy and caries-active subjects changes from month 2 to week 4
Time Frame: Changes from month 2 to week 4 (Baseline)
Saliva and dental plaque will be collected during the study visit. The amount of ammonia produced via the ADS by oral bacteria present in the collected oral samples will be measured using a standardized protocol.
Changes from month 2 to week 4 (Baseline)
Levels of the arginine deiminase system (ADS) in oral samples of healthy and caries-active subjects changes from week 4 to week 2
Time Frame: Changes from week 4 to week 2 (Washout)
Saliva and dental plaque will be collected during the study visit. The amount of ammonia produced via the ADS by oral bacteria present in the collected oral samples will be measured using a standardized protocol.
Changes from week 4 to week 2 (Washout)
Levels of the arginine deiminase system (ADS) in oral samples of healthy and caries-active subjects changes from week 2 to week 8
Time Frame: Changes from week 2 to week 8 (Evaluation)
Saliva and dental plaque will be collected during the study visit. The amount of ammonia produced via the ADS by oral bacteria present in the collected oral samples will be measured using a standardized protocol.
Changes from week 2 to week 8 (Evaluation)
Levels of the arginine deiminase system (ADS) in oral samples of healthy and caries-active subjects changes from week 8 to week 12
Time Frame: Changes from week 8 to week 12 (Evaluation)
Saliva and dental plaque will be collected during the study visit. The amount of ammonia produced via the ADS by oral bacteria present in the collected oral samples will be measured using a standardized protocol.
Changes from week 8 to week 12 (Evaluation)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bacteria collected from oral samples of healthy and caries-active subjects changes from baseline to month 2
Time Frame: Changes from baseline to month 2 (Screening)
Saliva and dental plaque will be collected during the baseline study visit. These oral samples will be plated in specific medium for bacterial growth and isolation. The isolated bacteria will be identified by molecular and microbiological techniques to characterize their capacity to produce ammonia from arginine - ADS activity. Protocols will be used to determine the sensitivity of the ADS of the oral isolates to environmental oral factors.
Changes from baseline to month 2 (Screening)
Bacteria collected from oral samples of healthy and caries-active subjects changes from month 2 to week 4
Time Frame: Changes from month 2 to week 4 (Baseline)
Saliva and dental plaque will be collected during the baseline study visit. These oral samples will be plated in specific medium for bacterial growth and isolation. The isolated bacteria will be identified by molecular and microbiological techniques to characterize their capacity to produce ammonia from arginine - ADS activity. Protocols will be used to determine the sensitivity of the ADS of the oral isolates to environmental oral factors.
Changes from month 2 to week 4 (Baseline)
Bacteria collected from oral samples of healthy and caries-active subjects changes from week 4 to week 2
Time Frame: Changes from week 4 to week 2 (Washout)
Saliva and dental plaque will be collected during the baseline study visit. These oral samples will be plated in specific medium for bacterial growth and isolation. The isolated bacteria will be identified by molecular and microbiological techniques to characterize their capacity to produce ammonia from arginine - ADS activity. Protocols will be used to determine the sensitivity of the ADS of the oral isolates to environmental oral factors.
Changes from week 4 to week 2 (Washout)
Bacteria collected from oral samples of healthy and caries-active subjects changes from week 2 to week 8
Time Frame: Changes from week 2 to week 8 (Evaluation)
Saliva and dental plaque will be collected during the baseline study visit. These oral samples will be plated in specific medium for bacterial growth and isolation. The isolated bacteria will be identified by molecular and microbiological techniques to characterize their capacity to produce ammonia from arginine - ADS activity. Protocols will be used to determine the sensitivity of the ADS of the oral isolates to environmental oral factors.
Changes from week 2 to week 8 (Evaluation)
Bacteria collected from oral samples of healthy and caries-active subjects changes from week 8 to week 12
Time Frame: Changes from week 8 to week 12 (Evaluation)
Saliva and dental plaque will be collected during the baseline study visit. These oral samples will be plated in specific medium for bacterial growth and isolation. The isolated bacteria will be identified by molecular and microbiological techniques to characterize their capacity to produce ammonia from arginine - ADS activity. Protocols will be used to determine the sensitivity of the ADS of the oral isolates to environmental oral factors.
Changes from week 8 to week 12 (Evaluation)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Salivary factors present in healthy and caries-active subjects during the research study.
Time Frame: Up to six months.
Saliva will be collected from healthy and caries-active subjects during the research study. Microbiological and molecular techniques such as microscopic observation of green birefringence, elisa assays and microRNA analysis will be used to determine and compare differences between salivary factors present in these two groups
Up to six months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Marcelle Nascimento, DDS, MS, PhD, University of Florida

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

November 1, 2014

Study Completion (Actual)

November 1, 2014

Study Registration Dates

First Submitted

April 25, 2014

First Submitted That Met QC Criteria

May 2, 2014

First Posted (Estimate)

May 5, 2014

Study Record Updates

Last Update Posted (Estimate)

November 9, 2016

Last Update Submitted That Met QC Criteria

November 7, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 665-2008
  • A-2013-197-OC (Other Identifier: Colgate Palmolive)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Caries

Clinical Trials on Caries Free

Subscribe